Search research articles
Contact Us
Filters
Showing results (41-50 of 81) with videos related to
Page
of 9
Sort By:
International Journal of Cancer
|
April 10, 1997
Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression
R G Vile, S Castleden, J Marshall, et al.
Virology
|
February 1, 1992
Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses
Y Takeuchi, G Simpson, R G Vile, et al.
Cytokine & Growth Factor Reviews
|
March 13, 2010
Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics
K J Harrington, R G Vile, A Melcher, et al.
Cancer Research
|
December 1, 1994
Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component
R G Vile, J A Nelson, S Castleden, et al.
The Journal of Urology
|
September 8, 2001
Gene therapy for prostate cancer: current status and future prospects
K J Harrington, C Spitzweg, A R Bateman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 10, 2001
Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy
C Spitzweg, K J Harrington, L A Pinke, et al.
Cancer Research
|
June 26, 1999
Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity
A Melcher, S Todryk, A Bateman, et al.
Journal of Virology
|
February 1, 1992
Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus
Y Takeuchi, R G Vile, G Simpson, et al.
Gene Therapy
|
September 16, 2011
Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling
D M Rommelfanger, C P Offord, J Dev, et al.
Virology
|
January 1, 1991
A murine cell line producing HTLV-I pseudotype virions carrying a selectable marker gene
R G Vile, T F Schulz, O F Danos, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 81) with videos related to
Sort By:
Page
of 9
International Journal of Cancer
|
April 10, 1997
Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression
R G Vile, S Castleden, J Marshall, et al.
Virology
|
February 1, 1992
Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses
Y Takeuchi, G Simpson, R G Vile, et al.
Cytokine & Growth Factor Reviews
|
March 13, 2010
Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics
K J Harrington, R G Vile, A Melcher, et al.
Cancer Research
|
December 1, 1994
Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component
R G Vile, J A Nelson, S Castleden, et al.
The Journal of Urology
|
September 8, 2001
Gene therapy for prostate cancer: current status and future prospects
K J Harrington, C Spitzweg, A R Bateman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 10, 2001
Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy
C Spitzweg, K J Harrington, L A Pinke, et al.
Cancer Research
|
June 26, 1999
Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity
A Melcher, S Todryk, A Bateman, et al.
Journal of Virology
|
February 1, 1992
Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus
Y Takeuchi, R G Vile, G Simpson, et al.
Gene Therapy
|
September 16, 2011
Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling
D M Rommelfanger, C P Offord, J Dev, et al.
Virology
|
January 1, 1991
A murine cell line producing HTLV-I pseudotype virions carrying a selectable marker gene
R G Vile, T F Schulz, O F Danos, et al.
Page
of 9